Total Funding
33
54
Total FundingDebt Financing raised
Growth Score
-31 pts
Heat Score
-6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
93421
FinVector is a world leader in the research and development of Viral-Based Gene Therapy products.
Janne Weisell: Process Development ManagerPast Role: FinVector, Senior Scientist
About the Company
FinVector is a world leader in the research and development of Viral-Based Gene Therapy products. Their state-of-the-art facilities, highly experienced scientific team and commitment to work closely with clients every step of the way, have helped us to build an excellent reputation in the gene therapy market. They are authorised under EMA for the
production of gene therapy products for clinical and commercial supply.
